More Information on 'MBL Beijing Biotech Co Ltd'

About MBL Beijing Biotech Co Ltd
Beijing Boer Mai Biotechnology Co., Ltd.(BEIJING B & M BIOTECH CO., LTD) was founded in 2005, is a Sino-Japanese joint venture high-tech enterprises. The company is based in Japan, Institute of Medical Biology (MBL Inc., Japan: Japanese listed companies, the internationally renowned production of clinical diagnostic reagents and the professional company in Japan, the United States, South Korea, has a large market share.) ; bring biological carrier company in Japan (Japan DNAVEC Company: specialized in biological technology development of Japan's leading research institutions, with strong technology base and advanced R & D capability.); and some Chinese experts in the field of biological science and technology investment form. On the ground in Beijing Economic and Technological Development Zone to invest in building a SPF-level antibody production base, equipped with advanced laboratory research equipment. Has a workforce of highly qualified and product development, production, marketing, planning, after-sales service team in one. Company targeting post-genome era of biotechnology and biomedical research and development needs, on the one hand, according to the world marketplace for scientific research needs to carry out a planned destination of antibody engineering studies, using genetic engineering methods developed various high-quality production of antibodies, the current large-scale product part of the exported overseas, has been unanimously praised by users at home and abroad; the other hand, sales from abroad, and biotechnology and biomedical research reagents needed front-line and clinical diagnostic reagents.